Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lunacalcipol in Stage 5 CKD with Secondary Hyperparathyroidism
NCT01453634Phase 2Withdrawn
- Sponsor
- OPKO Health
- Start
- Jan 2013
- Primary completion
- Jul 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of lunacalcipol in secondary hyperparathyroidism (SHPT), sponsored by OPKO Health. Planned start Jan 2013; status: withdrawn.
02
Drugs
lunacalcipol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT01453634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01453634.